Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTH (1-84) imaging study in postmenopausal women with primary osteoporosis
2006-005570-42Phase 4Active
- Sponsor
- Nycomed
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of parathyroid hormone 1-84 in postmenopausal osteoporosis and involutional osteoporosis, sponsored by Nycomed. Started Jul 2007; status: active.
02
Drugs
parathyroid hormone 1-84
03
Conditions
postmenopausal osteoporosisinvolutional osteoporosis
Beyond the preview
Go deeper on 2006-005570-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005570-42.